NOVABAY PHARMACEUTICALS INC - COM (NBY)

CUSIP: 66987P300

Q1 2024 13F Holders as of 31 Mar 2024

Share change
-754,745
SEC-reported price per share
$0.10
Indexed holders
12
Value change
-$189,197
Number of buys
6
Number of sells
8

Security key

66987P300

Report period

Q1 2024

Indexed institutions

12

Top holders

9

Ownership snapshot

Top reported holders of NBY - NOVABAY PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Xinzhou Li
Disclosed value leader
Andrew D. Jones
Comparable rows
0/15
Latest evidence
31 Dec 2023
3/4/5 13F Highest disclosed value: $230,704 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Andrew D. Jones has the largest disclosed position value at $230.7K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Andrew D. Jones's linked filing trail.
Disclosed position value Top 5
Xinzhou Li $54.3K
Andrew D. Jones $230.7K
Justin Hall $150.5K
ARMISTICE CAPITAL, LLC $146.6K
RENAISSANCE TECHNOLOGIES LLC $32K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Xinzhou Li
3/4/5
Director, 10%+ Owner
—
denominator unverified
$54,300
30,000 shares
— 21 May 2021
Andrew D. Jones
3/4/5
CFO
—
denominator unverified
$230,704
127,461 shares
— 15 Feb 2023
Justin Hall
3/4/5
CEO, GC and Director, Director
—
denominator unverified
$150,541
83,172 shares
— 14 Sep 2022
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$146,629
718,768 shares
— 31 Dec 2023
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$32,000
155,523 shares
— 31 Dec 2023
Altium Capital Management LLC
13F
Company
13F
—
denominator unverified
$13,761
67,457 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
12
Shares
434,296
Indexed holders
12
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 indexed holders
19
Q1 2024 indexed holders
12
Indexed holder difference
-7
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .